Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | GAA | P10253 | 5/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28083810 | 0.83 | ALDH1A1 (0.46) | ALDH1A1GAAMGAMSIMGAM2 | |
| SCHEMBL9574919 | 0.82 | GAA (0.44) | ALDH1A1GAAMGAMSIMGAM2 | |
| SCHEMBL3907402 | 0.78 | GAA (0.41) | ALDH1A1GAAMGAMSIMGAM2 | |
| SCHEMBL355253 | 0.78 | GAA (0.55) | ALDH1A1GAAMGAMSIMGAM2 | |
| SCHEMBL25961960 | 0.76 | GAA (0.42) | ALDH1A1GAAMGAMSIMGAM2 | |
| SCHEMBL5138578 | 0.75 | GAA (0.46) | ALDH1A1GAAMGAMSIMGAM2 | |
| SCHEMBL18048520 | 0.74 | — | — | |
| SCHEMBL3836989 | 0.73 | GAA (0.44) | ALDH1A1GAAMGAMSIMGAM2 | |
| SCHEMBL5639931 | 0.73 | GAA (0.46) | ALDH1A1GAAMGAMSIMGAM2 | |
| SCHEMBL11651480 | 0.72 | LMNA (0.48) | ALDH1A1GAAMGAMSIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180339963-A1 | ANTICONVULSANT CARBAMATE DERIVATIVES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2018-11-29 | — | — | US | disclosed |
| CN-1057779-C | N-sulfamino-polymer, fibre formed from it, and their magnetic recording medium | SANYO CHEMICAL IND LTD (JP) | 2000-10-25 | — | — | CN | disclosed |
| CN-1133304-A | N-sulfamino-polymer, fibre formed from it, and their magnetic recording medium | SANYO CHEMICAL IND LTD (JP) | 1996-10-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180339963-A1 | ANTICONVULSANT CARBAMATE DERIVATIVES | CNR2, GRIK5, GRIK4 | ALDH1A1 1380/4885GAA 2879/4885MGAM 3348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.